We present the clinical case of a young man who has undergone surgery for multiple intestinal perforations secondary to cutaneous malignant melanoma metastatic implants.
Case report
Patient aged 23, with a history of resection of cutaneous melanoma and left axillary lymphadenectomy as a consequence of metastatic adenopathies of one year evolution, and "interferon" as adjuvant treatment. He was admitted to Oncology due to a severe vasogenic oedema and displacement of the midline secondary to unique cerebral metastasis in the left parietal lobe. During admission he presents a clinical picture of abdominal distension associated with pain and guarding of hypogastrium-RIF, the abdominal X-ray showing: distended loops of the small intestine and descending colon, an abdominal CT scan revealing pneumoperitoneum with free peritoneal liquid ( Fig. 1 ). In the face of these findings he was submitted to urgent surgery, which revealed a generalized peritonitis secondary to perforation of the small intestine in 3 segments located in the proximal and distal jejunum, on the level of the distal ileum, related to cutaneous melanoma metastatic implants. Resection of the affected intestine was carried out. The postoperative evolution was satisfactory and the patient was discharged on the 10 th day. The anatomopathological study confirmed the diagnosis of intestinal metastasis from cutaneous malignant melanoma (Fig. 2) The patient died at home, 5 months later, due to the progression of the disease.
Discussion
At present, metastatic melanoma is considered to be a practically incurable disease. The survival rate for patients with distant metastasis is 5-10% at 5 years and 2% at 15 years (4).
Gastrointestinal metastases from melanoma reflect an advanced stage of the disease, clinically undetectable in the initial phases. The diagnosis is normally carried out because of complications, which means that the principal aim of the treatment should be to palliate the latter (5).
Some series have shown increased survival in the group with complete resection of these lesions. Berger et al published a study of 50 patients with melanoma metastatic to the gastrointestinal tract, 37 of whom were submitted to surgical resection, those submitted to complete resection with a median survival of 23.5 months, compared with 8.9 months in patients submitted to partial resection (5, 6) .
Until only a few decades ago, the surgical treatment of metastatic melanoma was contemplated as a medical intervention which only makes any sense in the case of symptomatic metastases causing obstruction or haemorrhage. It is now known that the palliative surgical removal of unique metastases implies a significant lengthening of disease free time, with the consequent increase in quality of life (4).
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